Abstract
Background
Assisted Reproductive Technologies (ART) are increasingly used in humans; however, their impact is now questioned. At blastocyst stage, the trophectoderm is directly in contact with an artificial medium environment, which can impact placental development. This study was designed to carry out an in-depth analysis of the placental transcriptome after ART in mice.
Methodology/Principal Findings
Blastocysts were transferred either (1) after in vivo fertilization and development (control group) or (2) after in vitro fertilization and embryo culture. Placentas were then analyzed at E10.5. Six percent of transcripts were altered at the two-fold threshold in placentas of manipulated embryos, 2/3 of transcripts being down-regulated. Strikingly, the X-chromosome harbors 11% of altered genes, 2/3 being induced. Imprinted genes were modified similarly to the X. Promoter composition analysis indicates that FOXA transcription factors may be involved in the transcriptional deregulations.
Conclusions
For the first time, our study shows that in vitro fertilization associated with embryo culture strongly modify the placental expression profile, long after embryo manipulations, meaning that the stress of artificial environment is memorized after implantation. Expression of X and imprinted genes is also greatly modulated probably to adapt to adverse conditions. Our results highlight the importance of studying human placentas from ART.
Introduction
It is estimated that 2.2% of children born each year in the United States were conceived with the help of assisted reproductive techniques (ART) including in vitro fertilization (IVF) and intra-cytoplasmic sperm injection (ICSI) [1]. Although these techniques are thought to be safe, new evidence suggests an increased risk of morbid congenital problems associated with their use [2], [3], such as cerebral palsy and delayed development [4], low birth weight [5], [6], and increased major birth defects [3], [5]–[9]. Furthermore, in recent years even if contradictory findings exist [9]–[12], several reports suggested that IVF increases the risk of epigenetic disorders [13], [14] including Beckwith–Wiedemann [15]–[19], Angelman [18], [20], [21] and Silver-Russell syndromes [22]–[24].
While infertility, per se, could be at least partly responsible for these diseases [25], the extent of the anomalies observed indicates that infertility alone does not explain all the alterations, part of them being certainly due to embryo culture and more generally to the reproductive technology applied to the gametes and the embryo. Indeed, studies in animal models have demonstrated that embryo culture [26], [27] and in vitro fertilization [28], [29] of mouse or bovine preimplantation embryos alter their gene expression patterns when compared with in vivo produced embryos. It is important to investigate whether these changes are only temporary or whether they may subsequently induce deleterious consequences. In mice, post-natal development and behavioral parameters (memory deficiencies at adult stage, altered behaviors and growth anomalies in standard tests) have been shown to be affected by embryo culture during the preimplantation period [30], [31]. These abnormal phenotypes could be the consequences of early (around implantation) gene profile modifications with persistent effects.
The placenta plays a crucial developmental function as the interface between the mother and the developing fetus. As such, it has been proposed to play the role of a filter against deleterious environmental influences, such as exposure to xenobiotics [32], toxins [33], [34], infectious agents and parasites [35]. In the present study, we analyzed the transcriptomic effects of in vitro embryo manipulations on the expression profile of placental genes (analyzed at 10.5 days post-fertilization, as depicted in Figure 1). We show that early manipulations are not completely buffered at post-implantation stage. In fact, roughly 6% of the transcripts are altered at the threshold of two-fold in placentas of manipulated embryos compared with placentas of embryos produced in vivo. In addition, we show by bioinformatics promoter analysis that specific transcription factors could be involved in these deregulations. Finally, we show that many imprinted genes known to be crucial for placental development [36], [37], are more deregulated than the rest of the transcriptome, and overall in the up-regulation direction contrarily to the rest of the genome. Many of these deregulated imprinted genes belong to the previously identified imprinted gene network [38], and some were previously found modulated by ART [14]; Fauque et al., submitted). Interestingly, we observe that like imprinted genes, genes from the X chromosome behave similarly to imprinted genes following IVF manipulations. We discuss the potential impact of these targeted modifications.
Results
IVF and Embryo Culture Trigger Substantial Transcriptional Modifications on Placental Gene Expression Profiles
The expression of placental genes was compared between placentas from the different groups (Figure 1). The Affymetrix 430 2.0 microarray that was used encompasses a complete set of mouse transcripts (45,101 transcripts). We calculated a ratio of modification for each gene, by pairwise comparisons between the three conditions (in vivo, in vitro M16, and in vitro G1/G2), in order to count how many genes were modified at the two-fold or four-fold thresholds (either up- or down-regulated), as shown in Table 1 and Figure 2. At the two-fold threshold, in vitro fertilization and embryo culture in M16 resulted in the overall deregulation of 3,553 transcripts compared to in vivo produced embryos, while G1/G2 culture induced the expressional alterations of 2,721 transcripts. At the four-fold threshold, the number of modified transcripts was reduced more than five times, with 703 and 494 misregulated transcripts after culture in M16 and G1/G2, respectively. Overall, the count of dysregulated transcripts after in vitro fertilization and embryo culture versus in vivo conditions was much higher than when the two in vitro conditions of embryo culture were compared (Table 1). The same idea is illustrated when all the transcripts were taken into consideration by a hierarchical clustering analysis of the expression profiles. This representation shows a striking separation into two major branches opposing the in vivo sample to the two in vitro samples (correlation coefficient between IVF M16 and IVF G1/G2 = 0.67, Figure 3). IVF M16 and IVF G1/G2 samples were further divided into two little branches (correlation coefficient IVF M16 versus control = 0.14 and IVF G1/G2 versus control = 0.27).
Table 1. Number of modified placental transcripts at the two-fold and four-fold thresholds.
IV vs M16 | IV vs G1/G2 | M16 vs G1/G2 | |
> two-fold up-regulated | 1340 (3.0%) | 1135 (2.5%) | 157 (0.3%) |
> two-fold down-regulated | 2213 (4.9%) | 1586 (3.5%) | 276 (0.6%) |
> four-fold up-regulated | 191 (0.4%) | 217 (0.4%) | 6 (0.0%) |
> four-fold down-regulated | 512 (1.1%) | 277 (0.6%) | 11 (0.0%) |
In addition, it was interesting to note that most genes modified by in vitro culture were down-regulated. This down-regulation was stronger with M16 than with G1/G2 (Figure 2).
Modified Genes Are Involved in Cell Growth, Protein Modifications, Immune Regulation, Complement and Coagulation, and Angiogenesis
After observing very few differences between the two media used for embryo culture, we performed functional clustering analyses by comparing control samples and samples from culture carried out in the G1/G2 sequential medium. The major reason for this choice was the fact that G1/G2 is one of the most classical medium used in human ART. The results are slightly milder than when M16 was used; however, they most generally occur in the same direction. For this analysis, we focused exclusively on genes (one gene being sometimes represented in the array by more than one transcript).
Seven hundred thirty eight genes (corresponding to 1,135 transcripts) induced more than two-fold in the IVF G1/G2 group, were submitted to the DAVID database to attempt a functional clustering [39], [40]. Three hundred ninety one (391) were successfully clustered into 27 functional groups, seven of which were significant according to the threshold defined (Figure 4A, see Materials and Methods). The functional classification of up-regulated genes from the IVF G1/G2 sample is summarized in Figure 4A. A large number of transcripts encoded proteins involved in growth hormone activity, cell division and mitosis, as well as DNA metabolism. These clusters suggest an increased activity of cell growth. The activated DNA metabolism may contribute to explain the massive transcriptional alterations observed on the arrays. An important category relates to protein modifications, essentially by the transcriptional activation of ubiquitin ligases.
A cluster of four apoptotic genes was found including the imprinted gene Peg3. This gene is a potential mediator of cell death that cooperates to the p53-mediated cell death pathway. A cluster involved in cellular bioenergetics (lipid metabolism) was also identified.
Figure 4B summarizes the gene clusters that were more than two-fold less abundant after embryo culture in G1/G2 (nine clusters, containing 82 genes, had an enrichment factor above the threshold and were thus analysed further). A large cluster of repressed genes encoded proteins that play a role in immune regulation (orosomucoid, serine peptidase inhibitors and cystatin-f). In addition, two clusters encompassing a total of 41 genes involved in angiogenesis, proteolysis and coagulation were found.
Moreover, modified genes, either up- or down-regulated (1000 transcripts in each category) were grouped into one file for analyzing enriched pathways using DAVID. This selection corresponds to a threshold of transcriptional down-regulation of 2.4 fold or less, and to 2.07 fold or more for induced genes. One thousand seven hundred and eleven (1,711) genes ID were recognized, 163 of which could be incorporated into 13 KEGG pathways. Among the detectable pathways that remain significant after Benjamini-Hochberg correction for multiple testing, we could identify three major groups of genes (Table 2): Complement and coagulation cascades, Natural killer-mediated cell toxicity and Cell adhesion molecules. The main features of these pathways are presented in Supplemental Figures S1, S2 and S3. This finding clearly demonstrates that IVF and embryo culture strongly down-regulate the genes involved in complement pathways, as shown in Supplemental S1. The expression levels of the pivotal molecules C3 and C5 were reduced 3.1 and 2.2 fold, respectively. The complement system behaves as an integrated module of factors, suggesting that one missing element in the cell membrane attack complex may be sufficient to inhibit cell lysis. As such, the sole induction of Complement factor 9, albeit strong (x4.5), is probably not sufficient to promote cell death since the other components are not transcriptionnally increased. Interestingly, in the second pathway significantly enriched (“Natural Killer Cell Mediated Cytotoxicity”, Supplemental S2), there is a very strong overrepresentation of down-regulated genes, suggesting that this pathway is blocked. Finally, the group of genes encoding molecules of cell adhesion is also considerably enriched in down-regulated genes, especially for genes involved in cell-cell signalling in the frame of the immune system (Supplemental S3). In this pathway, many genes are down-regulated more than five-fold (Icos, Itgal, Itgb2, Ptprc, Selplg). In almost all these cases, the gene expression alterations induced by culture in M16 were slightly stronger (data not shown), but the clusters and pathways identified were the same.
Table 2. KEGG pathways identified starting analysis from the 2000 most modified genes in the placenta after IVF and embryo culture.
Term | Gene Count | % | P-Value | Benjamini | |
KEGG_PATHWAY | Complement and coagulation cascades | 30 | 1.8 | 2.3E-12 | 4.4E-10 |
KEGG_PATHWAY | Natural killer cell mediated cytotoxicity | 29 | 1.7 | 0.000015 | 0.0014 |
KEGG_PATHWAY | Cell adhesion molecules (CAMs) | 32 | 1.9 | 0.000026 | 0.0017 |
KEGG_PATHWAY | PPAR signaling pathway | 16 | 0.9 | 0.0042 | 0.19 |
KEGG_PATHWAY | C21-Steroid hormone metabolism | 6 | 0.4 | 0.006 | 0.21 |
KEGG_PATHWAY | ECM-receptor interaction | 16 | 0.9 | 0.016 | 0.4 |
KEGG_PATHWAY | Leukocyte transendothelial migration | 20 | 1.2 | 0.016 | 0.36 |
KEGG_PATHWAY | Fructose and mannose metabolism | 10 | 0.6 | 0.029 | 0.51 |
KEGG_PATHWAY | Pentose phosphate pathway | 7 | 0.4 | 0.031 | 0.49 |
KEGG_PATHWAY | Hematopoietic cell lineage | 14 | 0.8 | 0.056 | 0.67 |
KEGG_PATHWAY | Glycolysis/Gluconeogenesis | 10 | 0.6 | 0.065 | 0.7 |
KEGG_PATHWAY | Renin-angiotensin system | 5 | 0.3 | 0.094 | 0.8 |
KEGG_PATHWAY | Bile acid biosynthesis | 7 | 0.4 | 0.1 | 0.79 |
Genes from the X Chromosome Are Specifically Modified (Essentially Up-Regulated) by IVF Manipulations
We attempted to analyze gene expression modifications according to the chromosome localization. We used the information available from the Affymetrix database to sort the data per chromosome, and we performed a Chi2 test to compare the number of induced/repressed/unmodified genes (at the two-fold threshold) between each chromosome and the rest of the genome (See the Supplemental Table S1). A correction was then applied in order to take into account the multiple testing; with this correction the statistical test was considered significant if below 0.0025. Using this threshold, only the X chromosome was different from the rest of the genome (Figure 5A, χ2-test = 2.8 10−30). This skewed proportion was essentially due to the striking abundance of up-regulated genes located on this chromosome (7.4% vs 2.6% for the rest of the genome). By contrast, repressed genes were not different (3.2% vs 3.6% for the rest of the genome). The effect on non pseudoautosomal X genes was apparently not linked to the distance from the X inactivation center (Xic) (Figure 6). This effect was not due to a skewed representation of male and female embryos in the different RNA pools that were used. Since at this early stage, sex determination is starting (Sry is expressed at 10.5 dpc, the possible skews in representation were followed using the expression levels of Y-specific markers such as UtY, which were not different between the groups. Moreover, a skewed representation of male and female embryos would have the same consequences on induced and repressed genes, which is not what we observed. Thus, the X-specific transcriptome modifications described here appear genuine.
Imprinted Genes Are Overrepresented among Modified Genes from the Placenta from IVF and Embryo Culture and Are Mostly Induced Compared to the Rest of the Transcriptome
Imprinted genes are known to play important functions in placental development, growth and physiology and are submitted to epigenetic control. Consequently, we analyzed them specifically in our study. Previous expression analysis of a subset of 19 imprinted genes belonging to the imprinted gene network [38] on the placental samples of the present study revealed that manipulated concepti display significantly disturbed levels of gene expression (Fauque et al., submitted). Here, using microarrays, we extend this vision to the complete known set of imprinted genes. Eighty-nine (89) genes known to be imprinted in mice were thus analyzed; seventeen (17) were increased more than two-fold, while eight were reduced more than two-fold by the IVF and embryo culture performed in G1/G2 medium relative to the in vivo condition. The microarray results were very similar to those observed by qRT-PCR on a sample of 15 imprinted genes (Figure 7). Compared to the rest of the transcripts, the imprinted genes differed very significantly (χ2-test = 1.53 10−24; figure 5B and see the Supplemental Table S2). In addition, it was striking that similarly to the X, the proportion of induced versus repressed genes was inverted compared to the rest of the transcriptome (19.1% induced and 9.0% repressed, versus 2.5% induced and 3.5% repressed in imprinted genes versus the other transcripts, respectively). Furthermore, for the imprinted genes that could be classified according to the expressed allele (paternal or maternal), it appears that while there was the same amount of induced and repressed maternally expressed genes (7 and 6 among 38, respectively), paternally expressed genes appeared primarily induced (7 induced, one repressed among 27 genes).
Promoter Analysis Reveals a Putative Role of FOXA Transcription Factors in Increasing the Expression of Placental Genes after IVF
To gain insight into the molecular bases of the aforementioned transcription alterations induced by IVF followed by embryo culture, we analyzed the promoter composition of 34 genes corresponding to the 17 most induced and the 17 most repressed, using Principal Component Analysis (PCA) (for details, see Materials and Methods section). Promoter regions were identified using the Gene2Promoter routine of the Genomatix software (http://genomatix.de). The number of putative promoters per gene ranged from one to five. In total, 60 promoters were identified (See the Supplemental Table S3). Then, putative TFBS were detected using Genomatix. In addition to the promoter composition, the level of induction/repression was added to the data matrix file as a variable for calculating the correlation matrix prior to PCA, which made it possible to identify axes 1 and 8 as strongly correlated with this parameter, while the other axes were not (Figure 8). The first axis was also correlated with the CpG composition (data not shown), indicating that genes induced by the IVF/embryo culture protocol have a fairly AT-rich content in their promoters, while repressed genes have a more GC-rich content in their promoters. Again, this is in accordance with the transcriptional induction of Dnmt3a, which can target specific promoters de novo, essentially if they are rich in CpG islands [41]. The binding sites of the transcription factors which are correlated with the “Induction Ratio” variable were V$LHXF, V$ATBF, V$HOXF, V$BRNF, V$HOMF on axis 1, and V$RXRF, V$AIRE, V$PLAG, V$FKHD, V$GLIF on axis 8, as referred to in the Genomatix database. The Promoter Content Principal Component Analysis (PCPCA) was thus able to diagnose TFBS that clustered on the promoters of induced genes. It was also interesting to identify whether one (or a few) of these TFBS was differentially represented in the two types of promoters. Student's t-test was therefore applied for each TFBS in order to contrast promoter contents between induced and repressed genes, after correction for multiple testing. The most differential binding site was the V$FKHD bound by “forkhead”-containing transcription factors (ForKHeaD), which was strongly over-represented in IVF-induced versus IVF-repressed genes (P = 0.001 after correction, Figure 9). Interestingly, this binding site was the only one to remain significant after correction, far beyond the next one V$HNF1 (p = 0.13). We then reanalyze the array data to check for the transcriptional level (induction/repression) of genes belonging to the FOX family, since the TFBS for FOX was overrepresented. FoxA1, FoxA2 and FoxA3 mRNAs were induced 3.3, 4.4 and 6.2 -fold, respectively. FoxJ2 gene coding another member of the forkhead transcription factors family was also induced by IVF manipulations (2.2-fold). Following these observations, we moved to expression of human placentas near term (controls and from IVF). Unfortunately, the expression level of these genes is so weak near term that comparisons are impracticable. We also explored a few placentas from the first trimester and could observe a much higher expression of FOXA1, A2 and A3 around 12 weeks of gestation (∼10–15 times, data not shown). These results are not incompatible with the idea that FOXA genes could be involved in human placenta modifications of gene expression when ART is used, but mostly at early stages of gestation when human samples are not accessible for testing.
Discussion
To the best of our knowledge, our study demonstrates for the first time a substantial alteration of placental gene expression following in vitro manipulation techniques of the embryo (above 6% of the transcripts), with a significant excess of repressed genes in the complete transcriptome. There are indications that epigenetic information could be modified in culture and be the cause of long term expressional modifications. Amongst epigenetic mediators, four Dnmt are known, amongst which, Dnmt3a and 3b are known to modify (and not only transmit from one cell generation to the other) epigenetic alterations. Therefore, our findings correlate very well with the overexpression of the Dnmt3a gene, encoding the DNA (cytosine-5-)-methyltransferase 3 alpha (x 2.6 in average), which could bring the genome to an overall overmethylation, thus inducing the down-regulation of many genes, especially when their promoter is GC-rich.
The alterations are observed more than 6 days after the in vitro manipulations (in vitro fertilization and embryo culture) meaning that a ‘memory’ of the injury has been stored during the differentiation of the placenta. These alterations may constitute an important subject of interrogation from the human point of view (for children conceived by ART). This is especially striking, due to the fact that part of the embryo culture of this study was carried out in G1/G2 medium, which is also classically used in humans. However, since the gamete manipulations and fertilization step was performed in M16 medium we can not excluded that this period of stress could contribute very significantly to the large effects seen. Additionally, recent studies have shown that embryo transfer and superovulation could modify imprinted gene expression [42], [43], it would be interesting to perform additional experiments including both variables (superovulation and embryo transfer).
Our data show that in vitro fertilization techniques trigger the induction of genes involved in cellular proliferation and cell cycle pathways and an alteration of genes involved in apoptosis pathways. This is probably linked to the invasive properties of trophoblast cells (which promote degradation of the extra-cellular matrix via the production of metalloproteases [44], [45]). Interestingly we observed a decrease in expression of genes involved in the angiogenic signaling, which may explain defects in the future placental function. In addition, repressed gene clusters encompassed genes of the immune system. During pregnancies obtained after IVF and embryo culture, the placenta could therefore be less able to play its protective filtering role against environmental aggressions (bacterial, viral or chemical). This result parallels some of the placental effects of IUGR monitored by transcriptomics in the rat model [46], where the levels of mRNA encoding genes protecting the foeto-placental unit against external aggressions (either xenobiotics or microbial) are reduced.
Interestingly, two categories of genes behave differently from the bulk of the genome: imprinted genes and X-borne genes. Indeed these genes are overall induced, while for the rest of the genome, the reverse situation is observed. Concerning imprinted genes, this observation is consistent with several reports in humans, suggesting that IVF increases the risk of diseases caused by aberrant genomic imprinting, such as Beckwith–Wiedemann syndrome (BWS) [15]–[19], Angelman syndrome (AS) [18], [20], [21] and Silver-Russell syndrome (SRS) [23], [24]. Thus, the epigenetic modifications induced at the early embryo stage [47]–[52] could persist at later stages of development. The observation that early injuries (before implantation) have consequences much later (on the placenta imprinting profile) is consistent with the literature, showing that tissues of trophectoderm origin are unable to restore a correct genomic imprint for the H19 gene [53] and adequate expression level of this gene [42]. Our results extend the expression anomalies on the complete category of imprinted genes, even showing that they behave differently than the other genes. Interestingly, we observe that the paternally expressed genes are almost systematically induced, which suggests a trend towards favoring placental growth and thus weighing in the balance towards the paternal side of the materno-paternal conflict [54]. Abundant literature suggests that the X inactivation processes share at least partly mechanisms of expression regulation with imprinted genes [55], [56]. Again, our results substantiate this observation. Interestingly, certain X-linked genes are required in mice for normal placental development and for embryonic growth and viability, as the Cited1 gene [57]. In our experimental groups, this gene was up-regulated (more than 4.5 fold). It is possible that the Cited1 gene can functionally compensate for the loss of other genes during embryonic development.
We discovered that the promoters of the most strongly activated genes are enriched in forkhead recognition sites, which could be linked to the overexpression of FoxA family genes. These genes could constitute key elements in the observed modifications in gene expression. FOXA proteins are critical for development, differentiation, and metabolism. In particular, mice homozygous for a null mutation in FOXA1 develop a complex phenotype characterized by growth and metabolic abnormalities and display a strong neonatal mortality between days 2 and 14 [58]. In addition, high expression of FOXA1 is commonly observed in prostate tumors. FOXA1 is known to be involved in translating epigenetic signatures since histone H3 lysine 4 dimethylation has been shown to guide FOXA1 recruitment [59], [60]. This may enhance transcription in a controlled fashion with cell type specificity by opening chromatin [61]. Therefore, our results suggest that since IVF results in the transcriptional induction of FoxA genes, this constitutes a pathway towards wide changes in gene expression, such as the one observed here. Furthermore, we showed that FoxJ2 was also up-regulated in IVF samples. FoxJ2 over-expression using transgenic mice has a negative effect on embryonic development [62].
Our data on the transcriptomic consequences of ART manipulations in the mouse model at the post-implantation stage establish expressional disturbances in placental tissues that consequently modify trophic adjustments and might be connected to birth weight, obesity, type II diabetes or hypertension later in life. Such differences have the potential to influence long-term patterns of gene expression that might be associated with increased risk of many human diseases. Additionally, our results suggest that a family of transcriptional regulators (FOXA) may be involved in the response to the injury in the placenta. In future studies, analysis of permanent tissues (such as liver, kidney, brain) in mice following ART will have to be performed.
Materials and Methods
Animals
Five- to six-week-old F1 (C57BL/6/CBA) females and eight- to nine-week-old F1 males (Charles River Laboratories, L'Arbresle, France) were maintained in an animal facility at normal temperature (21–23°C) and 14 h light/10 h dark photoperiods with free access to water and food. Procedures for handling and experimentation followed ethical guidelines established by the Federation of European Laboratory Animal Science Associations.
Experimental Design
All female mice were superovulated and were divided into three different experimental groups (IVF in M16 medium, IVF in G1/G2 medium groups versus control group). In the control group, blastocysts were collected after in vivo fertilization and in vivo development. In the two IVF groups, blastocysts were obtained after in vitro fertilization and development. The embryos from IVF were cultured either in M16 medium (IVF M16 group; Sigma-Aldrich, Lyon, France) or in sequential G1/G2 medium (G1.G2 group; JCD Laboratories, Lyon, France) respectively. All embryos were then transferred to pseudopregnant females.
Superovulation
Females were superovulated by intraperitoneal (i.p.) injection of 8 IU (0.1 ml) Pregnant Mare Serum Gonadotropin (PMSG, Chronogest; Intervet, Beaucouzé, France), followed 47 h later by an i.p. injection of 5 IU (0.1 ml) of human Chorionic Gonadotropin (hCG, Chorulon; Intervet).
In vitro fertilization and embryo culture
Thirteen hours post-hCG, cumulus-oocyte complexes were recovered from oviducts in M2 medium (Sigma-Aldrich) supplemented with 7 mg/ml of BSA (Sigma-Aldrich). After rinsing in M16 medium, cumulus-oocyte complexes were kept in the incubator (37°C, 5.5% CO2 in air) in 100 µl drops of M16 medium covered with paraffin oil (Vitrolife). Spermatozoa were collected from the cauda epididymis and capacitated for 90 min in M16 medium supplemented with 7 mg/ml of BSA at 37°C and 5.5% CO2. Oocytes were inseminated 15 h post-hCG with 106 spermatozoa. Fertilized eggs (23 h post-hCG) as determined by the presence of two pronuclei were then transferred to 30 µl drops of fresh medium covered with paraffin oil. To analyze the embryo culture medium effects, two different media were tested: the M16 medium and the sequential G1/G2 medium [63] containing amino acids. The embryo culture was conducted up to the blastocyst stage at 37°C and 5.5% CO2. The culture medium was changed daily.
Collection of blastocysts
Recipient F1 females were mated individually with F1 males after hCG injection. The following morning, females were checked for vaginal copulation plug. Embryos at the blastocyst stage were obtained by flushing the uterus 3.5 days p.c. with M2 medium supplemented with BSA (7 mg/ml).
Embryo transfer recipients
F1 (C57BL/6/CBA) females of at least 6 weeks of age were mated to vasectomized F1 males 1 day prior to embryo transfer. The morning after mating, females were checked for the presence of a vaginal plug, and this was considered as day 0.5 of pseudopregnancy. A total of 40 and 51 embryos (at early, non expanded and fully expanded blastocyst stages, classification described in our previous study, [52]) were transferred to the uteri of pseudopregnant females of control and IVF groups respectively, on pseudopregnant d3.5 according to standard procedures [42]. On day 10.5, females were sacrificed and concepti with a normal development (stage 17–18 as defined by Theiler et al., [64]) were immediately collected (Supplemental Table S4). After removal of yolk sac and embryos, placentas were dropped in 250 µl of Trizol reagent (Invitrogen Life Technology, Cergy, France), snap-frozen and stored at –80°C until further use.
RNA Preparation, cDNA Synthesis, and Microarray Hybridizations
RNA preparation
Total RNA was extracted from a pool of five placental samples coming from at least two litters from the same group with Trizol (Invitrogen Life Technology) according to the manufacturer's instructions and treated with DNase I to eliminate genomic DNA contamination. The integrity of the total RNA was investigated using the Bioanalyser 2100 and the RNA 6000 nano LabChip kit (Agilent Technologies). Only total RNA samples with a RIN number >8 were used.
cRNA synthesis and probe array hybridization
cRNA synthesis was performed using 3 µg of total RNA using the GeneChip Expression 32 Amplification One-Cycle Target Labelling, purified and fragmented before hybridization onto the mouse Affymetrix 430.2.0 GeneChips (Affymetrix Inc., Santa Clara, CA, USA) according to the manufacturer's protocol. Briefly, total RNA was first reverse transcribed using a T7-Oligo(dT) promoter primer in the first-strand cDNA synthesis reaction. Following RNase H-mediated second-strand cDNA synthesis, the double-stranded cDNA was purified and served as a template in the subsequent in vitro transcription (IVT) reaction. The IVT reaction was carried overnight at 37°C using the T7 RNA polymerase and a biotinylated nucleotide analog/ribonucleotide mix to generate labeled complementary RNA (cRNA). The biotinylated cRNA targets were then cleaned up, fragmented, and controlled on bioanalyzer 2100 before hybridization on murine GeneChip 430 2.0 expression arrays. After washing and staining using the specific protocols on the fluidics station FS450 (Affymetrix, Inc.), the chips were scanned with the GeneChip Scanner 3000 according to the manufacturer's instructions (GeneChip Analysis Technical Manual, www.affymetrix.com).
Microarray Gene Expression Data Analysis
The quality controls of the hybridization were performed using the MAS5 algorithm (implemented in GCOS software from Affymetrix) to determine the percentage of present probe sets for each chip of the study: close values were obtained in the range of expected values for high quality data according to Affymetrix standards (52.2%, 53.6%, 53.1% for control, M16 and G1/G2, respectively).
The dataset was then analyzed with GeneSpring (software version 7.2 -Agilent Technologies, France) for data analysis. The robust multiarray analysis algorithm (RMA, GeneSpring; Agilent Technologies) was applied to the data for background adjustment, normalization, and log2 transformation of perfect match values [65].
Functional clustering by DAVID (Database for Annotation and Visualization and Integrated Discovery)
Two lists of genes induced or repressed twice or more in the placentas were submitted to the DAVID database [40]. Briefly, DAVID clusterizes genes from a list according to a series of keywords common to several genes from the list. The proportion of each keyword from the gene list submitted is compared with the proportion in the whole genome, making it possible to compute a P value. Enrichment values are then calculated as the geometric mean of the inverse log of each P value. These enrichment scores depend on the number of genes present in the list. Therefore, we used a simulation to define minimal enrichment thresholds enabling us to identify gene clusters given by DAVID for further analysis, as previously described [46]. The groups were considered significant if they showed an enrichment value greater than 1.75 and 2.70 for induced and repressed gene clusters, respectively.
Promoter content principal component analysis (PCPCA)
A set of genes presenting an average of at least two-fold induction/repression calculated from the different probes specific for each gene spotted on the Affymetrix chip was selected for promoter analysis. Among these genes, the 17 most induced genes and the 17 most repressed were chosen. Putative promoter regions were automatically identified by using the Gene2Promoter routine of Genomatix (Munich, Germany) software (http://genomatix.de). The putative transcription factor binding sites (TFBS) were detected by using the Gene2Promoter function of the Genomatix software (Genomatix.de). The putative TFBS composition of 27 promoters from induced genes and 33 promoters from repressed genes was used to generate a correlation matrix of 153 rows [all the 152 putative TFBS detected by Genomatix and the log2 (induction ratio) for each gene] and 60 columns (See the Supplemental Table S3). This table was used to generate a correlation matrix, which allowed us to identify Eigen values and principal components, using the principal component utility from the StatistiXL software (http://www.statistixl.com). The Eigen values were classified in decreasing order to define the corresponding axes, the first axis collecting the highest percentage of information.
KEGG pathways
Differentially expressed genes in IVF versus control were classified in pathways established by the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways [66].
Quantitative RT–PCR Analysis in Mouse
The analysis of imprinted gene expression was performed in a previous study (Fauque et al., submitted) according to published protocols [38].
Human Patients
Placentas from control and ART patients were collected from the Saint Vincent de Paul maternity hospital, Paris. Informed consent was obtained from the patients under the auspices of a CPP (Committee for Patient Protection, Paris Cochin), in conformity with the Helsinki declaration. Total placental RNA was obtained from isolated placental villi dissected free from maternal membranes in HBSS on the maternal side as previously described [67]. Fragments were frozen in Trizol™ prior to RNA extraction, which was carried out according to previously published protocols [67].
RNA Extraction and cDNA synthesis in Human
Total RNA was extracted using Trizol Reagent (Invitrogen) in accordance with the manufacturer's instructions. cDNA synthesis was performed using Superscript cDNA synthesis kit (Invitrogen).
Quantitative RT-PCR analysis in Human
Quantitative RT PCR was performed using a Light Cycler (Roche) and the Invitrogen kit (SYBR®). The primers for cDNA amplification (see Supplemental Table S5) were chosen using the PRIMER3 software (http://frodo.wi.mit.edu/cgi-bin/primer3) with SDHA as one of the best reference genes for placental structures [68].
Statistics
Student's t -test, ANOVA and Mann–Whitney nonparametric tests were used throughout the study, with a P<0.05 threshold considered significant.
Supporting Information
Footnotes
Competing Interests: The authors have declared that no competing interests exist.
Funding: This research was supported by grants from the “Fond d'Aide la Recherche d'Organon” (ALA-570/06) and from the “Agence de Biomedecine” (06.21.DPM OMA 09), France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
References
- 1.Wright VC, Chang J, Jeng G, Macaluso M. Assisted reproductive technology surveillance–United States, 2005. MMWR Surveill Summ. 2008;57:1–23. [PubMed] [Google Scholar]
- 2.El-Chaar D, Yang Q, Gao J, Bottomley J, Leader A, et al. Risk of birth defects increased in pregnancies conceived by assisted human reproduction. Fertil Steril. 2009;92:1557–1561. doi: 10.1016/j.fertnstert.2008.08.080. [DOI] [PubMed] [Google Scholar]
- 3.Hansen M, Bower C, Milne E, de Klerk N, Kurinczuk JJ. Assisted reproductive technologies and the risk of birth defects–a systematic review. Hum Reprod. 2005;20:328–338. doi: 10.1093/humrep/deh593. [DOI] [PubMed] [Google Scholar]
- 4.Stromberg B, Dahlquist G, Ericson A, Finnstrom O, Koster M, et al. Neurological sequelae in children born after in-vitro fertilisation: a population-based study. Lancet. 2002;359:461–465. doi: 10.1016/S0140-6736(02)07674-2. [DOI] [PubMed] [Google Scholar]
- 5.Olson CK, Keppler-Noreuil KM, Romitti PA, Budelier WT, Ryan G, et al. In vitro fertilization is associated with an increase in major birth defects. Fertil Steril. 2005;84:1308–1315. doi: 10.1016/j.fertnstert.2005.03.086. [DOI] [PubMed] [Google Scholar]
- 6.Merlob P, Sapir O, Sulkes J, Fisch B. The prevalence of major congenital malformations during two periods of time, 1986–1994 and 1995–2002 in newborns conceived by assisted reproduction technology. Eur J Med Genet. 2005;48:5–11. doi: 10.1016/j.ejmg.2005.01.019. [DOI] [PubMed] [Google Scholar]
- 7.Hansen M, Kurinczuk JJ, Bower C, Webb S. The risk of major birth defects after intracytoplasmic sperm injection and in vitro fertilization. N Engl J Med. 2002;346:725–730. doi: 10.1056/NEJMoa010035. [DOI] [PubMed] [Google Scholar]
- 8.Klemetti R, Gissler M, Sevon T, Koivurova S, Ritvanen A, et al. Children born after assisted fertilization have an increased rate of major congenital anomalies. Fertil Steril. 2005;84:1300–1307. doi: 10.1016/j.fertnstert.2005.03.085. [DOI] [PubMed] [Google Scholar]
- 9.Kallen B, Finnstrom O, Nygren KG, Olausson PO. In vitro fertilization (IVF) in Sweden: risk for congenital malformations after different IVF methods. Birth Defects Res A Clin Mol Teratol. 2005;73:162–169. doi: 10.1002/bdra.20107. [DOI] [PubMed] [Google Scholar]
- 10.Bowdin S, Allen C, Kirby G, Brueton L, Afnan M, et al. A survey of assisted reproductive technology births and imprinting disorders. Hum Reprod. 2007;22:3237–3240. doi: 10.1093/humrep/dem268. [DOI] [PubMed] [Google Scholar]
- 11.Manning M, Lissens W, Bonduelle M, Camus M, De Rijcke M, et al. Study of DNA-methylation patterns at chromosome 15q11–q13 in children born after ICSI reveals no imprinting defects. Mol Hum Reprod. 2000;6:1049–1053. doi: 10.1093/molehr/6.11.1049. [DOI] [PubMed] [Google Scholar]
- 12.Tierling S, Souren NY, Gries J, Lo Porto C, Groth M, et al. Assisted reproductive technologies do not enhance the variability of DNA methylation imprints in human. J Med Genet. 2009 doi: 10.1136/jmg.2009.073189. [DOI] [PubMed] [Google Scholar]
- 13.Gomes MV, Gomes CC, Pinto W, Jr, Ramos ES. Methylation pattern at the KvDMR in a child with Beckwith-Wiedemann syndrome conceived by ICSI. Am J Med Genet A. 2007;143:625–629. doi: 10.1002/ajmg.a.31628. [DOI] [PubMed] [Google Scholar]
- 14.Katari S, Turan N, Bibikova M, Erinle O, Chalian R, et al. DNA methylation and gene expression differences in children conceived in vitro or in vivo. Hum Mol Genet. 2009 doi: 10.1093/hmg/ddp319. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.DeBaun MR, Niemitz EL, Feinberg AP. Association of in vitro fertilization with Beckwith-Wiedemann syndrome and epigenetic alterations of LIT1 and H19. Am J Hum Genet. 2003;72:156–160. doi: 10.1086/346031. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Gicquel C, Gaston V, Mandelbaum J, Siffroi JP, Flahault A, et al. In vitro fertilization may increase the risk of Beckwith-Wiedemann syndrome related to the abnormal imprinting of the KCN1OT gene. Am J Hum Genet. 2003;72:1338–1341. doi: 10.1086/374824. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Maher ER, Brueton LA, Bowdin SC, Luharia A, Cooper W, et al. Beckwith-Wiedemann syndrome and assisted reproduction technology (ART). J Med Genet. 2003;40:62–64. doi: 10.1136/jmg.40.1.62. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Ludwig H. Archives of Gynecology and Obstetrics: 135 years. Arch Gynecol Obstet. 2005;271:1–5. doi: 10.1007/s00404-004-0711-1. [DOI] [PubMed] [Google Scholar]
- 19.Halliday J, Oke K, Breheny S, Algar E, D JA. Beckwith-Wiedemann syndrome and IVF: a case-control study. Am J Hum Genet. 2004;75:526–528. doi: 10.1086/423902. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Orstavik KH, Eiklid K, van der Hagen CB, Spetalen S, Kierulf K, et al. Another case of imprinting defect in a girl with Angelman syndrome who was conceived by intracytoplasmic semen injection. Am J Hum Genet. 2003;72:218–219. doi: 10.1086/346030. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Cox GF, Burger J, Lip V, Mau UA, Sperling K, et al. Intracytoplasmic sperm injection may increase the risk of imprinting defects. Am J Hum Genet. 2002;71:162–164. doi: 10.1086/341096. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Douzgou S, Mingarelli R, Tarani L, De Crescenzo A, Riccio A. Silver-Russell syndrome following in vitro fertilization. Pediatr Dev Pathol. 2008;11:329–331. doi: 10.2350/08-04-0458.1. [DOI] [PubMed] [Google Scholar]
- 23.Bliek J, Terhal P, van den Bogaard MJ, Maas S, Hamel B, et al. Hypomethylation of the H19 gene causes not only Silver-Russell syndrome (SRS) but also isolated asymmetry or an SRS-like phenotype. Am J Hum Genet. 2006;78:604–614. doi: 10.1086/502981. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Kagami M, Nagai T, Fukami M, Yamazawa K, Ogata T. Silver-Russell syndrome in a girl born after in vitro fertilization: partial hypermethylation at the differentially methylated region of PEG1/MEST. J Assist Reprod Genet. 2007;24:131–136. doi: 10.1007/s10815-006-9096-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Kovalevsky G, Rinaudo P, Coutifaris C. Do assisted reproductive technologies cause adverse fetal outcomes? Fertil Steril. 2003;79:1270–1272. doi: 10.1016/s0015-0282(03)00397-2. [DOI] [PubMed] [Google Scholar]
- 26.Rinaudo PF, Giritharan G, Talbi S, Dobson AT, Schultz RM. Effects of oxygen tension on gene expression in preimplantation mouse embryos. Fertil Steril. 2006;86:1252–1265, 1265 e1251–1236. doi: 10.1016/j.fertnstert.2006.05.017. [DOI] [PubMed] [Google Scholar]
- 27.Rinaudo P, Schultz RM. Effects of embryo culture on global pattern of gene expression in preimplantation mouse embryos. Reproduction. 2004;128:301–311. doi: 10.1530/rep.1.00297. [DOI] [PubMed] [Google Scholar]
- 28.Giritharan G, Talbi S, Donjacour A, Di Sebastiano F, Dobson AT, et al. Effect of in vitro fertilization on gene expression and development of mouse preimplantation embryos. Reproduction. 2007;134:63–72. doi: 10.1530/REP-06-0247. [DOI] [PubMed] [Google Scholar]
- 29.Corcoran D, Fair T, Park S, Rizos D, Patel OV, et al. Suppressed expression of genes involved in transcription and translation in in vitro compared with in vivo cultured bovine embryos. Reproduction. 2006;131:651–660. doi: 10.1530/rep.1.01015. [DOI] [PubMed] [Google Scholar]
- 30.Ecker DJ, Stein P, Xu Z, Williams CJ, Kopf GS, et al. Long-term effects of culture of preimplantation mouse embryos on behavior. Proc Natl Acad Sci U S A. 2004;101:1595–1600. doi: 10.1073/pnas.0306846101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Fernandez-Gonzalez R, Moreira P, Bilbao A, Jimenez A, Perez-Crespo M, et al. Long-term effect of in vitro culture of mouse embryos with serum on mRNA expression of imprinting genes, development, and behavior. Proc Natl Acad Sci U S A. 2004;101:5880–5885. doi: 10.1073/pnas.0308560101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Polgar O, Robey RW, Bates SE. ABCG2: structure, function and role in drug response. Expert Opin Drug Metab Toxicol. 2008;4:1–15. doi: 10.1517/17425255.4.1.1. [DOI] [PubMed] [Google Scholar]
- 33.Marin JJ, Macias RI, Serrano MA. The hepatobiliary-like excretory function of the placenta. A review. Placenta. 2003;24:431–438. doi: 10.1053/plac.2002.0951. [DOI] [PubMed] [Google Scholar]
- 34.Marin JJ, Macias RI, Briz O, Perez MJ, Blazquez AG, et al. Molecular bases of the fetal liver-placenta-maternal liver excretory pathway for cholephilic compounds. Liver Int. 2008;28:435–454. doi: 10.1111/j.1478-3231.2008.01680.x. [DOI] [PubMed] [Google Scholar]
- 35.Beeson JG, Duffy PE. The immunology and pathogenesis of malaria during pregnancy. Curr Top Microbiol Immunol. 2005;297:187–227. doi: 10.1007/3-540-29967-x_6. [DOI] [PubMed] [Google Scholar]
- 36.Fowden AL, Sibley C, Reik W, Constancia M. Imprinted genes, placental development and fetal growth. Horm Res. 2006;65(Suppl 3):50–58. doi: 10.1159/000091506. [DOI] [PubMed] [Google Scholar]
- 37.Hemberger M. Epigenetic landscape required for placental development. Cell Mol Life Sci. 2007;64:2422–2436. doi: 10.1007/s00018-007-7113-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Varrault A, Gueydan C, Delalbre A, Bellmann A, Houssami S, et al. Zac1 regulates an imprinted gene network critically involved in the control of embryonic growth. Dev Cell. 2006;11:711–722. doi: 10.1016/j.devcel.2006.09.003. [DOI] [PubMed] [Google Scholar]
- 39.Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4:44–57. doi: 10.1038/nprot.2008.211. [DOI] [PubMed] [Google Scholar]
- 40.Dennis G, Jr, Sherman BT, Hosack DA, Yang J, Gao W, et al. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol. 2003;4:P3. [PubMed] [Google Scholar]
- 41.Turek-Plewa J, Jagodzinski PP. The role of mammalian DNA methyltransferases in the regulation of gene expression. Cell Mol Biol Lett. 2005;10:631–647. [PubMed] [Google Scholar]
- 42.Rivera RM, Stein P, Weaver JR, Mager J, Schultz RM, et al. Manipulations of mouse embryos prior to implantation result in aberrant expression of imprinted genes on day 9.5 of development. Hum Mol Genet. 2008;17:1–14. doi: 10.1093/hmg/ddm280. [DOI] [PubMed] [Google Scholar]
- 43.Fortier AL, Lopes FL, Darricarrere N, Martel J, Trasler JM. Superovulation alters the expression of imprinted genes in the midgestation mouse placenta. Hum Mol Genet. 2008;17:1653–1665. doi: 10.1093/hmg/ddn055. [DOI] [PubMed] [Google Scholar]
- 44.Husslein H, Haider S, Meinhardt G, Prast J, Sonderegger S, et al. Expression, regulation and functional characterization of matrix metalloproteinase-3 of human trophoblast. Placenta. 2009;30:284–291. doi: 10.1016/j.placenta.2008.12.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Hohn HP, Denker HW. Experimental modulation of cell-cell adhesion, invasiveness and differentiation in trophoblast cells. Cells Tissues Organs. 2002;172:218–236. doi: 10.1159/000066965. [DOI] [PubMed] [Google Scholar]
- 46.Buffat C, Boubred F, Mondon F, Chelbi ST, Feuerstein JM, et al. Kidney gene expression analysis in a rat model of intrauterine growth restriction reveals massive alterations of coagulation genes. Endocrinology. 2007;148:5549–5557. doi: 10.1210/en.2007-0765. [DOI] [PubMed] [Google Scholar]
- 47.Khosla S, Dean W, Brown D, Reik W, Feil R. Culture of preimplantation mouse embryos affects fetal development and the expression of imprinted genes. Biol Reprod. 2001;64:918–926. doi: 10.1095/biolreprod64.3.918. [DOI] [PubMed] [Google Scholar]
- 48.Li T, Vu TH, Ulaner GA, Littman E, Ling JQ, et al. IVF results in de novo DNA methylation and histone methylation at an Igf2-H19 imprinting epigenetic switch. Mol Hum Reprod. 2005;11:631–640. doi: 10.1093/molehr/gah230. [DOI] [PubMed] [Google Scholar]
- 49.Sasaki H, Ferguson-Smith AC, Shum AS, Barton SC, Surani MA. Temporal and spatial regulation of H19 imprinting in normal and uniparental mouse embryos. Development. 1995;121:4195–4202. doi: 10.1242/dev.121.12.4195. [DOI] [PubMed] [Google Scholar]
- 50.Mann MR, Chung YG, Nolen LD, Verona RI, Latham KE, et al. Disruption of imprinted gene methylation and expression in cloned preimplantation stage mouse embryos. Biol Reprod. 2003;69:902–914. doi: 10.1095/biolreprod.103.017293. [DOI] [PubMed] [Google Scholar]
- 51.Doherty AS, Mann MR, Tremblay KD, Bartolomei MS, Schultz RM. Differential effects of culture on imprinted H19 expression in the preimplantation mouse embryo. Biol Reprod. 2000;62:1526–1535. doi: 10.1095/biolreprod62.6.1526. [DOI] [PubMed] [Google Scholar]
- 52.Fauque P, Jouannet P, Lesaffre C, Ripoche MA, Dandolo L, et al. Assisted Reproductive Technology affects developmental kinetics, H19 Imprinting Control Region methylation and H19 gene expression in individual mouse embryos. BMC Dev Biol. 2007;7:116. doi: 10.1186/1471-213X-7-116. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Mann MR, Lee SS, Doherty AS, Verona RI, Nolen LD, et al. Selective loss of imprinting in the placenta following preimplantation development in culture. Development. 2004;131:3727–3735. doi: 10.1242/dev.01241. [DOI] [PubMed] [Google Scholar]
- 54.Moore T, Haig D. Genomic imprinting in mammalian development: a parental tug-of-war. Trends Genet. 1991;7:45–49. doi: 10.1016/0168-9525(91)90230-N. [DOI] [PubMed] [Google Scholar]
- 55.Okamoto I, Otte AP, Allis CD, Reinberg D, Heard E. Epigenetic dynamics of imprinted X inactivation during early mouse development. Science. 2004;303:644–649. doi: 10.1126/science.1092727. [DOI] [PubMed] [Google Scholar]
- 56.Lee JT. Molecular links between X-inactivation and autosomal imprinting: X-inactivation as a driving force for the evolution of imprinting? Curr Biol. 2003;13:R242–254. doi: 10.1016/s0960-9822(03)00162-3. [DOI] [PubMed] [Google Scholar]
- 57.Rodriguez TA, Sparrow DB, Scott AN, Withington SL, Preis JI, et al. Cited1 is required in trophoblasts for placental development and for embryo growth and survival. Mol Cell Biol. 2004;24:228–244. doi: 10.1128/MCB.24.1.228-244.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Shih DQ, Navas MA, Kuwajima S, Duncan SA, Stoffel M. Impaired glucose homeostasis and neonatal mortality in hepatocyte nuclear factor 3alpha-deficient mice. Proc Natl Acad Sci U S A. 1999;96:10152–10157. doi: 10.1073/pnas.96.18.10152. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Kininis M, Kraus WL. A global view of transcriptional regulation by nuclear receptors: gene expression, factor localization, and DNA sequence analysis. Nucl Recept Signal. 2008;6:e005. doi: 10.1621/nrs.06005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Lupien M, Eeckhoute J, Meyer CA, Wang Q, Zhang Y, et al. FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription. Cell. 2008;132:958–970. doi: 10.1016/j.cell.2008.01.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Cirillo LA, Lin FR, Cuesta I, Friedman D, Jarnik M, et al. Opening of compacted chromatin by early developmental transcription factors HNF3 (FoxA) and GATA-4. Mol Cell. 2002;9:279–289. doi: 10.1016/s1097-2765(02)00459-8. [DOI] [PubMed] [Google Scholar]
- 62.Martin-de-Lara F, Sanchez-Aparicio P, Arias de la Fuente C, Rey-Campos J. Biological effects of FoxJ2 over-expression. Transgenic Res. 2008;17:1131–1141. doi: 10.1007/s11248-008-9214-3. [DOI] [PubMed] [Google Scholar]
- 63.Guerif F, Le Gouge A, Giraudeau B, Poindron J, Bidault R, et al. Limited value of morphological assessment at days 1 and 2 to predict blastocyst development potential: a prospective study based on 4042 embryos. Hum Reprod. 2007;22:1973–1981. doi: 10.1093/humrep/dem100. [DOI] [PubMed] [Google Scholar]
- 64.Andras Nagy MG, Vintersten Kristina, Richard Richard. Manipulating the Mouse Embryo: A Laboratory Manual. 2003.
- 65.Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, et al. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res. 2003;31:e15. doi: 10.1093/nar/gng015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Kanehisa M, Goto S, Kawashima S, Nakaya A. The KEGG databases at GenomeNet. Nucleic Acids Res. 2002;30:42–46. doi: 10.1093/nar/30.1.42. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Mondon F, Mignot TM, Rebourcet R, Jammes H, Danan JL, et al. Profiling of oxygen-modulated gene expression in early human placenta by systematic sequencing of suppressive subtractive hybridization products. Physiol Genomics. 2005;22:99–107. doi: 10.1152/physiolgenomics.00276.2004. [DOI] [PubMed] [Google Scholar]
- 68.Meller M, Vadachkoria S, Luthy DA, Williams MA. Evaluation of housekeeping genes in placental comparative expression studies. Placenta. 2005;26:601–607. doi: 10.1016/j.placenta.2004.09.009. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.